Hypothesis

Central cholinergic enhancement via piracetam + choline increases vagal efferent output, driving acetylcholine release onto intestinal muscarinic M3 receptors on enteroendocrine L‑cells. This triggers GLP‑1 and PYY secretion, improves gut barrier function, shifts the microbiome toward a longevity‑promoting profile, reduces systemic inflammaging, and ultimately extends lifespan. If vagal efferent signaling or gut M3 receptors are blocked, the lifespan benefit will be abolished, falsifying the hypothesis.

Mechanistic Rationale Beyond Cited Work

In C. elegans, cholinergic motor neurons switch from ACR‑6‑mediated lifespan shortening to GAR‑3‑mediated extension via HSF‑1 activation. We propose an analogous temporal receptor switch in mammalian gut: early‑life M2 autoreceptor activation limits acetylcholine release and gut motility, whereas sustained central cholinergic tone later in life favors M3‑β‑arrestin signaling that activates epithelial HSF‑1 and upstream AKT‑mTORC1 pathways, promoting stress resistance and autophagy. This dual‑receptor model explains why indiscriminate cholinergic agonists have failed to extend lifespan—without the proper temporal pattern they may exacerbate M2‑mediated inhibitory tone.

Experimental Design

Subjects: 20‑month‑old C57BL/6J mice (n=10 per group). Groups: 1) Vehicle control; 2) Piracetam + choline (P+C) 300 mg/kg + 100 mg/kg daily; 3) P+C + atropine (muscarinic antagonist, 1 mg/kg i.p.); 4) P+C + subdiaphragmatic vagotomy; 5) P+C + GLP‑1 receptor antagonist (exendin‑9, 100 µg/kg). **Readouts (baseline, 3 mo, 6

Hypothesis

XX cells maintain higher basal NADPH production through dosage‑dependent expression of the X‑linked glucose‑6‑phosphate dehydrogenase (G6PD) gene, which fuels glutathione reductase and enhances GST‑mediated clearance of 4‑hydroxynonenal (HNE) and malondialdehyde (MDA) adducts on mitochondrial proteins. This hormone‑independent mechanism provides a biochemical basis for the observed female longevity advantage independent of gonadal steroids.

Mechanistic Rationale

• G6PD resides on the X chromosome and, although subject to X‑inactivation, a subset of alleles escapes silencing in many tissues, yielding ~1.3‑fold higher mRNA in XX versus XY cells [1].
• NADPH generated by G6PD drives the reduction of oxidized glutathione (GSSG) back to GSH, sustaining the glutathione‑dependent detoxification of lipid‑derived aldehydes by glutathione S‑transferases (GSTs) [2].
• Mitochondrial proteins are primary targets of HNE/MDA adduct accumulation with age, and their modification correlates with loss of enzyme activity in genotypes that show age‑related carbonyl stress [3][4].
• Thus, increased X‑linked G6PD dosage could lower steady‑state HNE/MDA adduct levels by bolstering the GSH‑GST pathway, independent of estrogen or testosterone signaling.

Testable Predictions

1. In gonad‑intact and gonadectomized mice, XX animals will exhibit lower mitochondrial HNE/MDA adduct burden than XY counterparts, regardless of gonadal sex.
2. Genetic reduction of G6PD activity (e.g., heterozygous G6pd knockdown) in XX mice will abolish the adduct difference, bringing XX levels up t

Hypothesis

Rapamycin extends lifespan not by repairing damage but by sustaining a cellular perception of nutrient scarcity; therefore, interventions that restore metabolic flexibility—such as L‑carnitine supplementation—should attenuate or abolish rapamycin‑dependent longevity benefits.

Mechanistic Rationale

Rapamycin inhibits mTORC1, shifting muscle metabolism toward fatty acid oxidation and increasing autophagy, mimicking the metabolic state of caloric restriction (CR) [1][2]. This shift reduces acetyl‑CoA availability, lowers protein synthesis, and activates stress‑responsive pathways (AMPK, SIRT1, FOXO) that promote survival under famine. Carnitine is essential for transporting long‑chain fatty acids into mitochondria; its supplementation reverses age‑related carnitine deficiency, boosts fatty acid oxidation, and increases acetylcarnitine efflux [2][3]. By replenishing the carnitine shuttle, L‑carnitine restores substrate flexibility and raises acetyl‑CoA levels, which would counteract the scarcity signal generated by mTORC1 inhibition. If the longevity effect hinges on maintaining a low‑energy, low‑acetyl‑CoA milieu, then rescuing acetyl‑CoA availability should blunt downstream autophagy and stress‑response activation, revealing whether rapamycin’s benefits are purely simulative.

Predictions

1. In aged mice, rapamycin alone will increase lifespa

Hypothesis

NMN‑induced NAD+ elevation directly activates SIRT6, which in turn downregulates the cystine transporter Slc7a11, raising hepatic hydrogen sulfide (H2S) production and deacetylating the autophagy adaptor p62 to shift cargo selectivity toward damaged mitochondria. This SIRT6‑H2S‑p62 axis accounts for the observed sex‑specific lifespan extension by NMN, as estrogen represses Slc7a11 transcription in females, limiting the downstream H2S surge.

Mechanistic Model

• NAD+ boost from NMN increases SIRT6 deacetylase activity (SIRT6 uses NAD+ as a co‑substrate) [3].
• Active SIRT6 deacetylates NAMPT, enhancing NAD+ salvage and creating a feed‑forward loop that sustains SIRT6 activity [7].
• SIRT6 directly deacetylates the cystine transporter Slc7a11 at lysine‑XX, reducing its membrane stability and promoting lysosomal degradation, thereby lowering cystine influx and increasing the intracellular cysteine pool for H2S synthesis via cystathionine beta‑synthase (CBS) [3, 4]
• Elevated H2S modifies p62 through persulfidation, facilitating its deacetylation by SIRT6 and altering its affinity for ubiquitinated mitochondria versus protein aggregates, thereby favoring mitophagy [[3](https://www.fightaging.org/archives/2025/11/mechanisms-likely-relevant

Hypothesis

Rapamycin extends lifespan by mimicking famine‑induced conservation programs, but its hormetic effect is limited when senescent‑cell‑derived SASP maintains a pro‑inflammatory milieu that antagonizes FOXO and NRF2 activation. Prior removal of senescent cells with a senolytic will therefore potentiate rapamycin‑driven lifespan and healthspan gains.

Mechanistic rationale

• Rapamycin inhibits mTORC1/2, shifting resources from growth to autophagy and stress resistance [1] [2].
• Senescent cells secrete IL‑6, IL‑1β and TGF‑β, which activate NF‑κB and STAT3 pathways that suppress FOXO transcriptional activity and blunt NRF2‑mediated antioxidant responses.
• Clearing senescent cells lowers circulating SASP factors, raising NAD+/NADH ratios and activating SIRT1, which deacetylates and stabilizes FOXO proteins and promotes NRF2 nuclear translocation.
• With SASP suppressed, rapamycin‑induced autophagy and reduced protein synthesis can more effectively engage FOXO/NRF2 target genes (e.g., SOD2, CAT, GCLC) without competing inhibitory signals.

Predictions

1. Mice receiving a senolytic (e.g., dasatinib + quercetin) followed by intermittent rapamycin will show a greater increase in median and maximum lifespan than either treatment alone.
2. The combination will produce lower plasma SASP biomarkers (IL‑6, TNF‑α) and higher hepatic FOXO1/NRF2 target expression than rapamycin monotherapy.
3. Healthspan metrics (grip strength, glucose tolerance, frailty index) will impr

The

hypothesis: Age-related enrichment of Parabacteroides goldsteinii elevates luminal medium-chain fatty acids (MCFAs) that cross the gut barrier, enter circulation, and are taken up by hippocampal neurons via monocarboxylate transporters. Once inside, MCFAs act as endogenous histone deacetylase (HDAC) inhibitors, increasing histone acetylation at promoters of senescence-associated genes (e.g., Cdkn2a/p16, Cdkn1a/p21) and driving a cell‑autonomous senescent phenotype in neurons, independent of systemic IL‑1β or endothelial senescence. This predicts that (1) hippocampal HDAC activity will be reduced in aged mice colonized with aged microbiota, (2) pharmacological neutralization of MCFAs or genetic ablation of neuronal HDAC3 will prevent MCFA‑induced senescence, and (3) rescuing HDAC activity will improve cognition even when systemic inflammation remains high.

Experimental design: Use young germ‑free mice colonized with either young‑donor or aged‑donor fecal microbiota. A third group receives aged microbiota plus daily oral gavage of an MCFA‑binding polymer (e.g., sulfonated polystyrene) to sequester luminal MCFAs. Measure hippocampal HDAC activity (fluorometric assay), global H3K27ac levels (Western blot), and neuronal senescence markers (p16, p21, SA‑β‑gal) by immunohistochemistry. Assess neurogenesis (BrdU+/NeuN+ cells) and cognitive performance (Morris water maze). In parallel, treat a subset of aged‑microbiota mice with a neuron‑specific HDAC3 activator via AAV‑HDAC3 to test rescue. Controls include vehicle‑gavaged aged‑microbiota mice and young‑microbiota mice re

Hypothesis

Repeated bouts of hormetic stress (e.g., exercise, fasting) followed by timed senolytic clearance convert the temporary protective pathways activated by hormesis into a cumulative reduction of senescent burden, thereby producing lasting tissue rejuvenation.

Mechanistic Rationale

• Hormetic stressors activate compensatory pathways (SIRT1, FOXO, HSPs, autophagy) but also generate new senescent cells, especially in aged tissues [4].
• Senescent cells secrete SASP factors that blunt the very stress‑response pathways hormesis relies on, creating a self‑limiting loop [4].
• Senolytics such as dasatinib + quercetin eliminate these senescent cells, rescuing the ability of hormetic stimuli to trigger adaptive signaling [4].
• If senolytics are administered after a hormetic bout, they remove the damage freshly created by that bout before SASP can accumulate and interfere with subsequent stress‑response activation.
• Over successive cycles, each hormetic episode adds a wave of transiently activated repair pathways, while the senolytic step permanently clears the senescent by‑product, allowing net damage to decline rather than remain flat.

Testable Predictions

1. Enhanced functional outcome – In aged mice, a regimen of weekly treadmill exercise followed 24 h later by dasatinib + quercetin will produce a greater increase in grip strength and endurance after 8 weeks than either exercise alone or senolytics alone.
2. **Redu

Hypothesis

Senescent cells export a soluble SASP component that directly activates mTORC1 in neighboring non‑senescent cells, thereby suppressing autophagy beyond the senescent compartment and establishing a self‑propagating suppression field that explains the systemic decline of autophagy in aged tissues.

Mechanistic Basis

• Senescent cells exhibit chronic mTORC1 hyperactivity that sustains SASP production via NF‑κB signaling [3].
• Recent data show that certain SASP factors (e.g., IL‑6, IGF‑BP7) can engage receptors on nearby cells and trigger PI3K‑Akt‑mTORC1 signaling [4].
• mTORC1 activation in recipient cells phosphorylates ULK1/ATG13 and retains TFEB in the cytoplasm, blocking autophagosome formation and lysosomal biogenesis [1].
• This creates a paracrine loop where autophagy suppression in bystander cells raises intracellular amino acids (through basal autophagy of their own proteins), further fueling mTORC1 activity and making the signal starvation‑insensitive.

Novel Insight

The field hypothesis posits that the SASP is not merely a biomarker of senescence but an active signaling agent that reprograms nutrient‑sensing pathways in adjacent cells. This extends the known intracellular autophagy‑SASP feedback [2, 5] to a tissue‑level communication network.

Testable Predictions

1. Conditioned medium transfer: Media fr

The autophagy‑lysosome pathway in Leydig cells does not merely bulk‑degrade cytoplasmic content; it selectively removes NHERF2, a brake on the cholesterol importer SR‑BI, thereby sustaining steroidogenesis. In young cells this selectivity is enforced by LIR‑dependent binding of NHERF2 to p62/SQSTM1, NBR1 and LC3. Aging, however, is associated with heightened ER stress and overall autophagic flux, yet testosterone output falls. We hypothesize that senescence does not diminish autophagy per se but reprograms its substrate hierarchy: stress‑activated kinases phosphorylate NHERF2 on residues within or near its LIR motif, reducing its affinity for canonical autophagy receptors. Consequently, p62 and NBR1 are rerouted toward alternative cargos such as mitochondrial proteins bound by BNIP3/NIX or ER residents recognized by FAM134B. The net effect is a shift from NHERF2‑centric autophagy to mitophagy/ER‑phagy, depleting cholesterol supply without altering total autophagosome numbers.

This mechanistic rewrite predicts three testable outcomes. First, immunoblotting of isolated young versus aged Leydig cells will reveal increased NHERF2 phosphorylation (e.g., at serine/threonine residues predicted by CDK2/AKT motifs) coinciding with reduced NHERF2‑LC3 colocalization and elevated NHERF2 protein levels despite unchanged LC3‑II turnover. Second, pharmacological inhibition of the responsible kinase (e.g., CDK2 inhibitor) or expression of a phospho‑deficient NHERF2 mutant (S/A substitutions) will restore NHERF2 degradation, increase SR‑BI surface expression, rescue cholesterol uptake, and

Central Hypothesis

Age‑related decline in BMAL1 expression desynchronizes not only NRF2‑mediated antioxidant defenses but also the metabolic switch from glycolysis to oxidative phosphorylation in club cells, driven by loss of BMAL1‑PPARα coupling. This dual desynchronization creates a permissive window for oxidative damage and faulty xenobiotic detoxification, pushing club cells toward a senescent, SASP‑secreting state that drives fibrosis rather than regeneration. Restoring circadian amplitude—either genetically (club‑cell‑specific BMAL1 overexpression) or pharmacologically (timed NAD⁺ boosting to enhance SIRT1‑BMAL1 activity)—will re‑align NRF2 oscillations with peak ROS and coordinate PPARα‑dependent fatty‑acid oxidation with the timing of CYP450 expression, thereby rescuing proliferative capacity and preventing fibrosis.

Mechanistic Rationale

1. BMAL1‑NRF2 axis – BMAL1 binds E‑boxes in the Nrf2 promoter, driving its circadian transcription. In aged club cells, dampened BMAL1 reduces the amplitude of Nrf2 mRNA and protein oscillations, causing antioxidant enzymes (e.g., GCLM, HO‑1) to be out‑of‑phase with mitochondrial ROS bursts that peak during the active phase.
2. BMAL1‑PPARα‑CYP450 axis – PPARα is a known BMAL1 target that governs fatty‑acid oxidation and regulates a subset of CYP450 genes (e.g., Cyp2a5, Cyp4a10). Loss of BMAL1 blunts PPARα rhythm, leading to mistimed phase‑I detoxification; toxic metabolites accumulate when antioxidant defenses are low.
3. Metabolic shift – Young club cells transition to OXPHOS during the rest phase to support rep

We hypothesize that the exponential coefficient observed in aging pseudotime trajectories directly reflects the rate of mitochondrial NAD+ turnover in a given cell type, and that alterations in this metabolic rate shift the position of cells along the quiescence‑senescence continuum. In other words, tissues with higher NAD+ consumption exhibit faster exponential aging pseudotime, pushing cells toward senescent states, whereas tissues that maintain NAD+ pools show slower exponential dynamics and prolonged quiescence.

Mechanistic basis

• Pseudotime models (Monocle, DPT, Palantir) capture a latent progress variable that correlates with mortality risk when fitted with two exponentials 3.
• Mitochondrial NAD+ is a key regulator of sirtuin activity, DNA repair, and metabolic signaling, all of which influence epigenetic drift and transcriptional aging signatures.
• Single‑cell multi‑omics studies have shown concurrent variation in NAD+ metabolic gene expression and epigenetic age across cells 4.
• We propose that the exponential term’s rate constant (k) is proportional to the average mitochondrial NAD+ flux per cell, making pseudotime a readout of metabolic aging speed.

Testable predictions

1. Perturbing mitochondrial NAD+ biosynthesis (e.g., by overexpressing or inhibiting NAMPT) will shift the exponential coefficient k of pseudotime trajectories in a predictable direction: increased NAD+ flux → larger k (faster aging); decreased NAD+ flux → smaller k (slower aging).
2. The shift i

Hypothesis

Clearing senescent cells with a senolytic dashatinib‑quercetin (D+Q) regimen before transient OSK expression will increase the efficiency and safety of epigenetic reprogramming by lowering SASP‑driven histone deacetylase (HDAC) activity that otherwise impedes TET‑dependent DNA demethylation.

Mechanistic Rationale

• Senescent cells secrete a senescence‑associated secretory phenotype (SASP) rich in IL‑6, TGF‑β, and PAI‑1, which activate SMAD and NF‑κB signaling pathways in neighboring cells.
• These pathways upregulate class I/II HDACs (e.g., HDAC1, HDAC2) leading to a more compact chromatin state that limits access of OSK factors to target loci and reduces TET enzyme activity.
• Senolytics such as D+Q selectively induce apoptosis in senescent cells, thereby decreasing SASP levels and downstream HDAC expression.
• Lower HDAC activity results in increased histone acetylation, a more open chromatin landscape, and enhanced TET‑mediated 5‑mC oxidation, facilitating the DNA demethylation waves observed during partial reprogramming.

Predictions

1. Primary – In aged mice, a regimen of D+Q followed by a single 1‑week OSKM induction will yield a greater reduction in epigenetic age (measured by Horvath‑style DNA methylation clocks) in liver, pancreas, and spleen compared with OSKM alone or D+Q alone.
2. Secondary – Tissue‑specific functional readouts (e.g., glucose tolerance test for pancreas, ALT/AST levels for liver, serum albumin for spleen) will show superior improvement only in the sequential group.
3. Mechanistic biomarker – HDAC1/2 protein levels

Hypothesis

Persistent pharmacological silencing of nociceptive signaling—particularly via TRPV1‑dependent pathways—reduces the release of calcitonin gene‑related peptide (CGRP) from sensory neurons. CGRP normally stimulates NAD+ biosynthesis in resident macrophages and endothelial cells through activation of the NAMPT enzyme. Lower NAD+ diminishes SIRT1 deacetylase activity, weakening the hormetic activation of mitochondrial unfolded‑protein response (UPRmt), autophagy, and DNA‑repair pathways that are triggered by low‑grade inflammatory stress. Consequently, long‑term analgesic use converts a protective, pain‑evoked mitohormetic signal into a chronic NAD+ deficit, promoting senescence‑associated phenotypes and shortening healthspan.

Mechanistic Rationale

1. Nociceptor‑CGRP‑NAD+ Axis – Injured or inflamed tissue activates TRPV1+ sensory neurons, triggering CGRP release. CGRP binds its receptor (RAMP1/CLR) on perivascular macrophages, elevating intracellular cAMP and stimulating NAMPT‑mediated NAD+ salvage (see [1] for CGRP‑immune modulation).
2. NAD+‑SIRT1 Mitohormesis – NAD+ fuels SIRT1, which deacetylates PGC‑1α, FOXO3a, and NF‑κB, promoting mitochondrial biogenesis, antioxidant defenses, and autophagy—core effectors of mild stress‑induced hormesis ([6]).
3. Analgesic Interruption – NSAIDs inhibit COX‑derived prostaglandins that sensitize TRPV1; opioids directly inhibit neuronal excitability. Both blunt CGRP efflux ([2],[4]), thereby decreasing macrophage NAD+ production.
4. Outcome – Reduced SIRT1 activity leads to accumulated acetyl‑p53, diminish

Hypothesis: Age-related decline in neuronal ATP production elevates extracellular adenosine, which activates microglial A2A receptors to increase complement C3 synthesis and synapse opsonization, thereby coupling metabolic inefficiency to complement-mediated synapse pruning.

Rationale: The seed idea frames neuronal loss in aging as an optimization process under falling energy budgets. Complement-dependent pruning is known to be overactive in aged brains, yet its selection criteria remain unclear. Extracellular adenosine rises when neuronal ATP falls (e.g., during hypoxia or metabolic stress) and is a potent modulator of microglial phenotype via A2A receptors, which can stimulate C3 transcription. This provides a plausible molecular bridge: metabolically weak neurons release more adenosine, tagging their synapses for microglial removal.

Mechanistic steps:

1. Aging neurons exhibit reduced mitochondrial oxidative phosphorylation, lowering intracellular ATP.
2. ATP depletion triggers increased extracellular ATP release through pannexin‑1/connexin‑43 hemichannels; extracellular ATP is rapidly hydrolyzed to adenosine by CD39/CD73 ectoenzymatic activity.
3. Elevated adenosine binds A2A receptors on microglia, raising cAMP and activating CREB‑dependent transcription of C3 and C1q.
4. Neuronal synapses with higher adenosine exposure acquire more C3b/iC3b opsonins, engaging microglial CR3 and leading to phagocytosis.
5. Synapses that maintain robust ATP output release less adenosine, escape tagging, and are preserved.

Testable predictions: - In aged mice, extracellular

Hypothesis

Clonal mtDNA heteroplasmy in proliferating germinal center (GC) B-cells reduces AID activity by (1) elevating mitochondrial ROS that causes off-target nuclear DNA damage at Ig loci, and (2) depleting acetyl‑CoA needed for histone acetylation that opens chromatin for AID access. Consequently, high heteroplasmy loads act as a selective bottleneck that skews affinity maturation toward lower‑affinity clones.

Testable predictions

• Prediction 1: GC B-cells isolated from aged mice will show a higher proportion of mtDNA heteroplasmy (>5% variant allele frequency) compared with young mice, and this proportion will inversely correlate with the frequency of high‑affinity antibodies in serum.
• Prediction 2: Pharmacological reduction of mitochondrial ROS (e.g., with MitoQ) in aged mice will decrease nuclear γH2AX foci in GC B‑cells and restore SHM fidelity without altering proliferation rates.
• Prediction 3: Supplying acetate to rescue acetyl‑CoA levels in B‑cells with induced mtDNA mutations will increase histone H3K27ac at the IgH locus and improve AID‑dependent mutation frequency, even when ROS remains elevated.

Experimental approach

1. Measure heteroplasmy: Single‑cell mtDNA sequencing of GC B‑cells (GL7+ CD95+) from young (3 mo) and aged (24 mo) mice; calculate variant allele frequency for each cell.
2. Correlate with output: Sort GC B‑cells into low (<2%) and high (>8%) heteroplasmy bins; assay SHM depth and bias in IgV genes via Ig‑seq; quantify serum antibody affinity using ELISA with increasing antigen concentrations.
3. **Intervene R

Hypothesis

Chronic obesity creates a hepatic choline sink that diverts circulating choline toward phosphatidylcholine synthesis for VLDL export, thereby lowering plasma choline availability for brain Kennedy pathway activity. This reduction impairs neuronal phosphatidylcholine production, elevates diacylglycerol‑derived lipid droplets, and promotes microglial activation, ultimately driving synaptic loss and cortical atrophy independent of genetic Kennedy pathway defects.

Mechanistic Rationale

• Hepatic choline demand rises in obesity – Expanded adipose tissue secretes leptin and inflammatory cytokines (TNF‑α, IL‑6) that upregulate hepatic CTP:phosphocholine cytidylyltransferase (CCTα) and PEMT activity to meet increased VLDL phosphatidylcholine needs for triglyceride export [1].
• Plasma choline falls – As hepatic choline is shunted into VLDL, less choline remains available for transport across the blood‑brain barrier via choline transporters (CHT1). Low plasma choline has already been linked to faster brain aging and elevated NfL [1].
• Brain Kennedy pathway slows – Reduced substrate limits CCTα‑catalyzed conversion of phosphocholine to CDP‑choline, decreasing phosphatidylcholine synthesis. The compensatory PEMT pathway cannot fully offset this deficit under choline‑limiting conditions, especially in aging brains

Hypothesis

The successful decidualization of endometrial stromal cells depends on a temporal hierarchy of selective autophagy: ER‑phagy precedes mitophagy, which precedes aggrephagy. Disrupting this order—by inducing mitophagy before ER‑phagy stalls—triggers a senescence‑like state that impairs decidualization, providing a mechanistic link between autophagy sequencing errors and reproductive aging.

Rationale

Recent work shows autophagy is essential for decidualization, with ATG5/ATG7 loss blocking the process[1]. Selective pathways are known: ER‑phagy via FAM134B[2], mitophagy via PINK1/Parkin[2], and aggrephagy for protein aggregates[3]. In other remodeling contexts, inflammation‑induced muscle atrophy displays a ordered ER clearance before mitochondrial turnover[5]. Yet no study has mapped when each selective autophagy pathway peaks during endometrial decidualization or how aging reshapes that timeline.

We propose that the cell treats autophagy as a cannibalism ritual where the order of cargo degradation encodes a survival program. Early ER‑phagy reduces unfolded protein load, safeguarding the secretory burst needed for decidual factors. Only after ER stress is mitigated does mitophagy remove damaged mitochondria, preventing ROS‑driven DNA damage. Finally, aggrephagy clears lingering aggregates, completing the remodeling. If mitophagy is activated prematurely—say by stress‑induced PINK1 stabilization before ER‑phagy finishes—the cell loses mitochondrial ATP while still burdened with ER stress, pushing p53‑AMPK‑mTOR toward senescence[4]. This mismatch

Hypothesis

Transient mRNA-delivered OSK, administered in pulsed cycles matching the dosing of viral OSKM, will achieve comparable tissue‑specific epigenetic rejuvenation and functional improvement as viral OSKM while maintaining a tumor‑free safety profile.

Rationale

• Non‑integrating mRNA eliminates insertional mutagenesis, a key safety advantage over viral vectors 1.
• Viral OSKM, despite integration risk, enables sustained factor expression that can drive robust epigenetic remodeling; however, continuous OSKM expression, especially with c‑Myc, triggers tumorigenesis in multiple organs 23.
• Short, cyclic OSK pulses (2‑4 days on, 5 days off) promote regeneration without tumors in muscle and intestine 45 and OSK alone extends lifespan in progeria/aged mice 6.
• We propose that the missing link between safety and efficacy is the Myc‑independent activation of the AMPK‑PGC‑1α axis. OSK (without Myc) can stimulate AMPK phosphorylation, leading to PGC‑1α‑driven mitochondrial biogenesis and enhanced NAD⁺/SIRT1 activity, which in turn facilitates DNA demethylation and histone turnover independent of HIF‑1α‑mediated hypoxia. This mitochondrial improvement reduces oxidative DNA damage, lowering the oncogenic pressure typically associated with

Hypothesis

Biological aging drives a progressive loss of higher‑order topological features (specifically persistent H2 voids) in the manifold of gene‑expression states, reflecting a collapse of multi‑way chromatin interactions that maintain transcriptional fidelity. This topological simplification can be quantified via persistent Laplacian spectra and will outperform conventional geometry‑based embeddings (UMAP/PCA) in predicting chronological age and correlating with molecular hallmarks of aging.

Mechanistic Rationale

Persistent H2 cavities in a point cloud of transcriptomic profiles arise when three or more expression patterns interact in a coordinated, non‑linear fashion across conditions, analogous to higher‑order chromatin loops that bring together enhancers, promoters, and insulators. As cells age, accumulating DNA damage, altered CTCF/cohesin dynamics, and histone‑modification drift weaken these multi‑way contacts, flattening the expression landscape and eliminating voids. Persistent Laplacians, which encode both topological and geometric information via eigen‑values of the up‑ and down‑Laplacian operators, are sensitive to the disappearance of such cavities while retaining sensitivity to local gene‑co‑expression clusters captured by H0 and H1. Thus, a spectral shift toward higher eigenvalues in the persistent Laplacian—indicating reduced void volume—should mirror the decline in chromatin‑loop complexity measured by Hi‑C.

Testable Predictions

1. Age‑related decline in persistent Betti number β₂: Across human GTEx tissues, the average persistence‑weight